Our preliminary studies have verified that the small molecules aminosteroid could inhibit the mRNA expression of bcr/abl fusion gene in CML (Chronic Myelogenous Leukemia) cells, which may be effective in treating CML and that may have dramatically different mechanism underlying the effects by tyrosine kinase inhibitors (TKI) binding to the BCR/ABL protein. Therefore, the exact mechanism of how the aminosteroid inhibited the CML growth should be clarified and we pay our attention to the promoter domain of BCR/ABL gene to see if any interaction between aminosteroid and the promoter. First, it should be verified if G-quadruplex could be formed in BCR/ABL promoter region.
Promoter

1.Introduction
Chronic myeloid leukemia (CML) is characterized by the chromosomal abnormality arising from a translocation between the long arms of chromosome 9 and chromosome 22 and generates the BCR/ABL fusion gene [1] . The 5'-sequences of the BCR gene including its promoter and coding sequences are fused to the 3'-sequences of the ABL gene in a head-to-tail fashion [ 2 , 3 ] . Therefore, a chimeric BCR/ABL mRNA transcribed from this fusion gene is initiated on the BCR gene promoter [ 4 , 5 ] . The BCR/ABL fusion protein produced from the chimeric gene is strongly associated with Ph positive leukemia and is directly or indirectly causative for this blood malignancy [ 6 ] because the protein exhibited an abnormal specific tyrosine protein kinase activity from the ABL moiety of the protein gene [ 7 ] . For the BCR/ABL fusion gene, all promoter activity localizes to 1 kb area in the 5'
-exon 1 of BCR coding sequences. This region contained six consensus binding sequences for transcription factor SP1 and two CCAAT boxes but no TATA-like sequences and the overall GC contents in BCR promoter region is 78%, of which the bases are from -735 bp to -1 bp relative to the known translation start site [ 8 ] . It was reported that the rich GC sequences in promoter rigion were easy to form a specific structure known as non-canonical four-stranded G-quadruplexe (G4) [ 9 ] . G-quadruplex structure formed from four guanine bases stabilized by Hoogsteen hydrogen bonding is one of the non-canonical secondary nucleic acid structures and is able to be further stabilized by the metal cations, which is widely existed in telomere promoters and some key regulatory regions of human
. And also, the G4 plays a vital role in a number of biological processes in vivo, including maintaining chromosome stability, DNA replication, transcription, genomic maintenance, RNA translational regulation, pre-mRNA splicing and gene expression [12, 13] . Recently, G-quadruplexe has been viewed as an emerging therapeutic target due to its specific promoter location and its selective oncogene promoter inhibition
. It was reported that the transcription of targeted gene in promoter regions can be effectively hindered by stabilizing the G-quadruplex structure with small molecule binding [ 1 6 ] . Small molecules as G-quadruplex probes have also been paid significant attention since accumulating evidence has been linked to G-quadruplex structure in many biological processes in vivo
.
Our previous work have proved that a kind of aminosteroids could inhibit the BCR/ABL fusion gene mRNA expression in CML cells and then inhibit the leukemia cell growth
. Thereafter, it is desired to figure out the mechanism underlying the effects of the aminosteroid. This prompts us to pay our attention to the BCR promoter region. We speculated that non-canonical four-stranded structure known as G-quadruplex (G4) may be formed in BCR gene promoter region because of high rate of GC contents similar with the c-myc oncogene promoter region [21] . And here our study showed that G-quadruplexe can be formed in BCR/ABL fusion gene promoter region verified by computer simulation, UV, CD and PCR stop assay. The interaction of aminosteroid with G-quadruplex formed in BCR/ABL promoter region was also verified by the above methods. The small molecule aminosteroid may become a new emerging therapeutic tool to target the BCR/ABL fusion gene in treatment of chronic myeloid leukemia.
2.Materials and Methods
Computational Prediction
The nucleotide sequences of BCR/ABL , Kras, c-kit, c-myc promoters and their complementary strands were obtained from NCBI ( The oligonucleotides of critical promoter sequences shown in Table 1 were synthesized and purified by Gen Script (Nanjing, Jiangsu, China).The DNA stock solutions were prepared by dissolving oligonucleotides directly in 10mM Tris HCl at pH of 7.4 with 100mM KCl followed by annealing on PCR circler (first heated at 95℃for 8min and cooled down at the rate of 3℃ per min to room temperature, then stored at 4℃ at least 6h before use ) for UV, CD and other detections. Aminosteroids (KH, BH, chemical structures in Fig.1 ) were synthesized in our laboratory and they were registered in CA as novel chemicals. Methylene Blue (MB) was purchased from Xiangya hospital (Changsha, China).
The stock solutions of aminosteroids and MB were prepared by dissolving them in ethanol and ultra-distilled pure water respectively. All of the other chemicals were of analytical reagent grade and used without further purification. Ultra-distilled pure water prepared using a Milli-Q Gradient ultra-distilled pure water system (Millipore) was used in all of the experiments. 
Circular dichroism
CD spectra were recorded on a Jasco J-815 spectrapolarimeter(JASCO, Japan) at a rate of experiments were at a concentration of 10uM in 10 mM Tris at pH 7.4 including 100 mM
KCl. The spectra were calculated with J-815 Standard Analysis Software (Japan Spectroscopic Co. Ltd) and were recorded as ellipticity (mdeg) versus wavelength (nm).
Each spectrum was recorded three times, smoothed and subtracted from the baseline.
UV−vis absorption spectra
The UV−vis absorption spectra (500−750 nm) detections were carried out with Varioskan
Flash technique at room temperature using 96 well UV microplate (from Corning, USA).
The DNAs and MB used in the UV−vis experiments were at a concentration of 10uM in 10 mM Tris at pH 7.4 including 100 mM KCl.
The fluorescence quenched measurements
The experiments were detected with 96 well microplate (Flat bottom, black polystyrol, from Corning, USA.) and the MB concentration was 10uM in 10 mM Tris at pH 7.4 including 100 mM KCl. All measurements were performed at room temperature and the fluorescence emission was recorded at 691nm with excitation at 666nm detected in fluorescence microplate reader .
Cell cultures and polymerase chain reaction stop assay
Chronic myeloid leukemia K562 cells were cultured in RPMI 1640 growth medium (Hyclone) containing L-glutamine (2 nM) , antibiotics (100 U/ml penicillin, 100 mg/ml streptomycin) and 10% fetal bovine serum (Sigma). Cells were maintained in logarithmic growth phase and genomic DNA was extracted by TIANamp Gemomic DNA kit (TIANGEN biotech, China). Polymerase chain reaction stop assay was carried out with 0.5uL universe high-fidelity hot start DNA polymerase , 0.5uL dNTP mix, 0.5uL DNA template , 1uL upstream primer and 1uL downstream primer (primers used in Table 2 ), 12.5uL 2×unverse buffer and 2.5uL of aminosteroids, then distilled water was added to 25uL of total reaction volume, circled at 95℃ 3min, 95℃15s, 60.2℃15s, 72℃ 10s for 34 cycles, ended at 72℃5min and kept at 4℃. The products were separated on a 2%
agarose gel prepared in TBE and the gel was exposed to autoradiograph. 3.2 G-quadruplex structure can be formed in BCR/ABL promoter regions and the aminosteroids interacted with the structure To verify the actual formation of G-quadruplexes predicted by QGRS Mapper , circular dichroism (CD) studies were performed on four oligonucleotides (3G4,4G4,5G4 and 8G4, Table 2 ).
3.Results
G-quadruplex can
Table2 Oligonucleotides used in the study
As we know, CD spectroscopy is a versatile tool to study secondary structures of nucleic acids, particularly DNA because this technique selectively distinguishes distinct conformational states of DNA depending on the salt and metal ion concentrations. CD spectra of 3G4,5G4 and 8G4 when not adding the aminosteroids showed both positive and negative CD signals at 260 and 240 nm respectively, suggesting the formation of a well-ordered parallel G-quadruplex structure. While the CD spectra of 3G4,5G4 and 8G4, when in the presence of aminosteroids, retained the both positive and negative CD signals at 260 and 240 nm respectively, but with a slight increase in CD intensity of the positive signal. CD spectrum of 4G4 showed a negative signal at 240 nm and two positive signals both at 260 nm and at 295 nm which revealed the formation of a typical hybrid G-quadruplex structure. CD data confirmed the existence of G-quadruplex structures in 3G4, 4G4, 5G4 and 8G4. Interestingly, aminosteriods could make it stable in the parallel and hybrid G-quadruplex structures (Fig.3) . Methylene blue (MB) is an organic dye with a positively charged aromatic structure that belongs to the phenothiazine family and it as a G-quadruplex binding probe acquires label-free homogeneous electrochemical biosensing ability
. It was reported that its derivatives were taken as c-myc G-quadruplex DNA stabilizers
, therefore we employed promoter region could form G-quadruplex structures and the aminosteroids could bind to the G-quadruplexes that were formed (Fig.4) . Furthermore, the specific probing of MB for DNA G-quadruplex structures was actually demonstrated by the UV-vis absorption spectra as shown in Fig.5 , and the MB solution induced bathochromic shifts from 666nm to 672nm, 673nm, 675nm, respectively, however, blue shifts from 672nm to 667nm was observed when adding the aminosteroids to the system. . However, it was seldom reported in leukemia such as CML.
Prediction of potential GQS relies on the folding rule: GxNy1GxNy2GxNy3Gx
. In which G represents guanine residues taking part in G-tetrad formation and x is the number of successive guanines. According to the folding rule, x is always constant and should be at least two because a minimum of two quartets is required to stack on top of each other to form a G-quadruplex. The lower scoring GQS will have two G-tetrads in its G-quadruplex entity and the stability is enhanced by more G-quartets or the number of guanine residues participating in the stacks. N is representative of the other bases involved in the loops of the G-quadruplex where N can be any base including guanine. y1, y2 and y3 are the frequency of the different residues that participate in the three different loops and they can vary. Loop size can affect stability of G-quadruplex ensembles but not as much as the frequency of guanine bases. GQSs having at least three guanine tetrads and loops of equal length connecting them will be highly stable and have high G-scores such as the positive controls.
CD is a powerful experimental method to examine the G-quadruplex structures as well as ligands binding of quadruplex DNAs or RNAs. It is special by comparing their spectra with those known quadruplex DNAs or RNAs structures [26, 27, 28] .The CD spectrum has the positive band near 260 nm and a negative band near 240 nm that are characteristics of an parallel known G-quadruplex structure. In the other respect, if CD spectrum is characteristic of a positive band near 260 and 290nm, then a negative band near 240nm, that means an hybrid structure existed (both parallel and anti-parallel structures) .
According to the above CD structure identification regulation, it was first discovered that the sequences in upstream of BCR/ABL promoter region which was the major transcription initiation site could be able to form four intramolecular G-quadruplex structures under similar physiological conditions. Furthermore, the G-quadruplex structures formed included two different kinds of structure topologies, namely both parallel and hybrid as verified in the results. Then, as the results, it was verified that aminosteroids KH and BH could stabilize both the G4 parallel and hybrid structures. It is therefore suggested that the interaction of aminosteroids with G-quadruplex formed in BCR/ABL promoter region may be a new potential therapeutic protocol in treatment of chronic myeloid leukemia.
Nowadays, people try to treat cancer such as leukemia by using gene therapy .
Generally, gene therapy needs a vector which is usually a virus to conduct a gene into cells, by which method, it could be called "biological gene therapy". Our protocol was to use a small molecule which could directly interfere with gene such as BCR/ABL promoter gene, in this way to do so-called "chemical gene therapy". In this method, we hope that the manipulation of targeted gene would be more simple, no vector needed and more applicable in future clinical translation. Thereafter, we found a potential way to make
